Brachytherapy for prostate cancer is the preferred treatment method at Cleveland Clinic for patients with localized prostate cancer. Jay Ciezki, MD, radiation oncologist, discusses the institution’s robust clinical and research program and asserts why physicians should consider it an effective therapy to potentially improve outcomes and decrease toxicity.
An animal model of brachytherapy-induced retinopathy would help investigators understand the underlying pathophysiological mechanisms. Cleveland Clinic researchers are creating one, which could eventually help test promising therapeutics.
A new study introduces a novel strategy of radiation therapy planning called temporally feathered radiation therapy (TFRT). The study presents a theoretical model and rationale behind TFRT that allows increased time for normal tissue recovery between radiation doses.
Dr. Shah’s team is preparing data for publication showing that cardiac doses at Cleveland Clinic are lower than the national standard by more than 50 percent.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Dr. Shah’s team is refining the use of intensity-modulated radiation therapy to deliver partial breast irradiation.
Cleveland Clinic’s team of radiation oncologists, medical physicists, dosimetrists, therapists and nurses optimizes patient safety, quality assurance and treatment delivery via a range of treatment options.
Oncologist discuss the latest discoveries and findings impacting radiation oncology at the 56th annual meeting